Compare · HIMS vs OPCH
HIMS vs OPCH
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.21B, about 1.9x OPCH ($3.21B).
- Over the past year, HIMS is down 48.7% and OPCH is down 38.9% - OPCH leads by 9.8 points.
- OPCH has been more active in the news (11 items in the past 4 weeks vs 8 for HIMS).
- HIMS has more recent analyst coverage (25 ratings vs 14 for OPCH).
- Company
- Hims & Hers Health Inc.
- Option Care Health Inc.
- Price
- $26.88+2.23%
- $20.45-3.99%
- Market cap
- $6.21B
- $3.21B
- 1M return
- +37.68%
- -26.32%
- 1Y return
- -48.66%
- -38.88%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 8
- 11
- Recent ratings
- 25
- 14
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest HIMS
- Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
- SEC Form DEFA14A filed by Hims & Hers Health Inc.
- SEC Form DEF 14A filed by Hims & Hers Health Inc.
- Analyst initiated coverage on Hims & Hers Health with a new price target
- SEC Form 4 filed by Okupe Oluyemi
- SEC Form 4 filed by Boughton Soleil
- SEC Form 4 filed by Okupe Oluyemi
- Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
- SEC Form 4 filed by Dudum Andrew
- SEC Form 4 filed by Okupe Oluyemi
Latest OPCH
- Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.
- Director Kraemer Harry M Jansen Jr bought $783,773 worth of shares (36,610 units at $21.41), increasing direct ownership by 9% to 450,000 units (SEC Form 4)
- Option Care Health Inc. filed SEC Form 8-K: Leadership Update
- Chief Financial Officer Sethna Meenal bought $327,075 worth of shares (16,225 units at $20.16), increasing direct ownership by 20% to 98,337 units (SEC Form 4)
- Chief Executive Officer Rademacher John Charles bought $264,706 worth of shares (12,500 units at $21.18), increasing direct ownership by 2% to 695,152 units (SEC Form 4)
- Option Care Health to Participate in the Bank of America Health Care Conference
- Option Care Health downgraded by BofA Securities with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits